Figure 2.
Day +100 hematologic responses for the 216 patients conditioned with PG-free MEL (Evomela®) and 200 patients condition with PG-solubilized MEL (Alkeran®) after ASCT, shown as the proportion of patients achieving each response category.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.